InvestSMART

Elixinol Wellness Limited (ASX: EXL) - Share Price

- Current share price for EXL : $0.006

Elixinol Wellness Limited (EXL) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It is involved in the global hemp industry, innovating, marketing, and selling hemp and other plant-derived food, skincare, and nutraceutical products.

EXL General Information +

ASX Code EXL
Website N/A
Industry/Sector Personal Products
Market Cap ($M) 2
EXL Share Price $0.006
Day High $0.007
Day Low $0.006
Last Close $0.006
EXL Share Price Movement - ( No change )
Prices as at 16:40, 29 Oct 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Elixinol Wellness Limited (EXL) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Final 10.5¢ 100% 4 Sep 2006 15 Sep 2006 - - -
Interim 13¢ 100% 28 Feb 2006 14 Mar 2006 - - -
Final 16¢ 100% 29 Aug 2005 16 Sep 2005 - - -

See all dividends from Elixinol Wellness Limited (EXL) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Elixinol Wellness Limited (EXL) price-sensitive announcements

EXL - Quarterly Activities/Appendix 4C Cash Flow Report
Elixinol Wellness Limited’s September 2026 quarterly activity report and Appendix 4C for Q
Elixinol Wellness Limited (EXL)
14 Oct 2026 | 8:29 AM
EXL - Elixinol Hemp Sales and Gross Profit Accelerate
Elixinol Wellness Limited announced that for the nine months to 30 September 2026, combine
Elixinol Wellness Limited (EXL)
13 Oct 2026 | 9:24 AM
EXL - EXL to Acquire Vitable Presentation
This presentation outlines Elixinol Wellness Limited’s proposed acquisition of Vitable und
Elixinol Wellness Limited (EXL)
24 Sep 2026 | 9:08 AM
EXL - EXL to Acquire Vitable
Elixinol Wellness Limited announced it has entered into a binding agreement to acquire the
Elixinol Wellness Limited (EXL)
24 Sep 2026 | 9:06 AM

Elixinol Wellness Limited (EXL) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Elixinol Wellness Limited (EXL)
ORDINARY FULLY PAID
Consumer Staple $3 The Healthy Chef Targets Creatine & Womens Wellness Market 28 Oct 2026 10:23AM $0.007 $0.006 fallen by 14.29%
Elixinol Wellness Limited (EXL)
ORDINARY FULLY PAID
Consumer Staple $3 Notification of cessation of securities - EXL 27 Oct 2026 5:41PM $0.007 $0.006 fallen by 14.29%
Elixinol Wellness Limited (EXL)
ORDINARY FULLY PAID
Consumer Staple $3 Appendix 3Y - Natalie Butler 27 Oct 2026 5:38PM $0.007 $0.006 fallen by 14.29%
Elixinol Wellness Limited (EXL)
ORDINARY FULLY PAID
Consumer Staple $3 Quarterly Activities/Appendix 4C Cash Flow Report 14 Oct 2026 8:29AM $0.006 $0.006 fallen by 0%
Elixinol Wellness Limited (EXL)
ORDINARY FULLY PAID
Consumer Staple $3 Elixinol Hemp Sales and Gross Profit Accelerate 13 Oct 2026 9:24AM $0.007 $0.006 fallen by 14.29%
Elixinol Wellness Limited (EXL)
ORDINARY FULLY PAID
Consumer Staple $3 Mt. Elephant launches national Cake Pods range 7 Oct 2026 9:46AM $0.007 $0.006 fallen by 14.29%

EXL Financial Summary

Year to Dec NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2025A -$5.07 -$2.00 86.80% 0.00 0.00 0.00% 0.0%
2024A -$1.64 -$1.10 -86.60% 0.00 0.00 0.00% 0.0%
2023A -$5.94 -$7.90 -58.50% 0.00 0.00 0.00% 0.0%

EXL Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2023 A 2024 A 2025 A 2023 A 2024 A 2025 A 2023 A 2024 A 2025 A
Elixinol Wellness Limited (EXL) $3M 0.8679 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%

EXL Directors

Name Position Start Date
Ms Natalie Butler Head of Marketing, Executive Director 28 Mar 2024
Mr Gavin Evans Non-Executive Chairman, Non-Executive Director 2 Dec 2025
Ms Pauline Therese Gately Non-Executive Director 17 Aug 2023

Elixinol Wellness Limited (EXL) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
18 Jun 2026 BUTLER, Natalie Sell Direct Shares 36,417 $0.006 $218.502
2 Jun 2026 EVANS, Gavin Buy Indirect Shares 496,636 $0.009 $4,221.406
30 Dec 2025 EVANS, Gavin Buy Indirect Shares 397,010 $0.010 $3,820.850

See all changes in directors' interest & trades for Elixinol Wellness Limited (EXL) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

EXL Management

Name Position
Adam Dimitropoulos Group Chief Financial Officer
Mariia Skorikova Joint Company Secretary
Tony Di Pietro Joint Company Secretary

EXL Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Elixinol Wellness Limited (EXL). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
52,812,092 (12.76%) Freedom Trader Pty Ltd
12,500,000 (6.40%) Stuart Reseck
12,500,000 (5.70%) Cutter Super Pty Ltd

EXL Calendar of Events

Date Event
30 August 2027 Report (Interim)
26 February 2027 Report (Annual)
26 February 2027 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.